Avalus Bioprostheses
Medtronic, Inc. · Decision date Feb 12, 2026
What did the FDA approve?
FDA records P170006/S040 as a supplement to PMA P170006, with the supplement type “135 Review Track For 30-Day Notice”. The recorded decision is approval, dated Feb 12, 2026.
FDA approval order statement
approval for a Pre-Determined Change Control Plan (PCCP) that establishes a standardized qualification process for new bovine and porcine tissue suppliers, provided they do not impact the tissue's specifications, the established methods for its sourcing, handling, and testing, or the qualification standards for supplier facilities and personnel for the devices under the above PMAs
- Regulatory pathway
- PMA supplement
- Supplement type
- 135 Review Track For 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Feb 12, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P170006/S040
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic, Inc.
- Product code
- LWR
- Decision code
- APPR
- Decision date
- Feb 12, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: heart-valve, non-allograft tissue.
- Applicant
- Medtronic, Inc.
- Product code
- LWR
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P170006/S040 received
Application receipt date recorded by FDA.
P170006/S039 · Related supplement
Avalus Bioprosthesis, Model 400
P170006/S041 · Related supplement
Avalus Bioprosthesis
P170006/S038 · Related supplement
Avalus Bioprosthesis, Avalus Ultra Bioprosthesis
P170006/S042 · Related supplement
Avalus Bioprosthesis Model 400 (40019, 40021, 40023, 40025, 40027, 40029); Avalus Ultra Bioprosthesis Model 400 (400U1
P170006/S040 · FDA decision
135 Review Track For 30-Day Notice
P170006/S043 · Related supplement
Avalus Bioprosthesis
P170006/S044 · Related supplement
Avalus Bioprosthesis, Model 400
P170006/S045 · Related supplement
Avalus Bioprosthesis
Timeline entries are records held by MedtechLedger for P170006. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P170006
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Avalus Bioprosthesis, Model 400P170006/S039 | Medtronic, Inc. | PMA supplement | Oct 23, 2025 | FDA |
Avalus BioprosthesisP170006/S041 | Medtronic, Inc. | PMA supplement | Oct 30, 2025 | FDA |
Avalus Bioprosthesis, Avalus Ultra BioprosthesisP170006/S038 | Medtronic, Inc. | PMA supplement | Nov 10, 2025 | FDA |
| Medtronic, Inc. | PMA supplement | Feb 4, 2026 | FDA | |
Avalus BioprosthesisP170006/S043 | Medtronic, Inc. | PMA supplement | Apr 9, 2026 | FDA |
Avalus Bioprosthesis, Model 400P170006/S044 | Medtronic, Inc. | PMA supplement | Jun 1, 2026 | FDA |
Avalus BioprosthesisP170006/S045 | Medtronic, Inc. | PMA supplement | Jul 9, 2026 | FDA |
Explore the linked device profile
Other records with product code LWR
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
EDWARDS INTUITY Elite Valve System (8300AB)P150036/S081 | Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA |
| Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 22, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Sep 18, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Aug 11, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 1851 E. Deere Ave., Santa Ana, CA, 92705
Sources and methodology
- Original FDA record: P170006/S040
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




